Fig. 9

DCA evaluates the clinical utility of REVEAL-Lite 2.0, REVEAL-ECHO, the current LV model, and the combined echo model by quantifying net benefit across a range of threshold probabilities for decision-making. The X-axis represents the threshold probability at which a clinical intervention would be triggered, and the Y-axis represents the mean net benefit compared with “treat all” and “treat none” strategies.